BRPI0801740A2 - agente de revestimento para stent de liberaÇço de fÁrmaco, mÉtodo para sua preparaÇço e stent de liberaÇço de fÁrmaco revestido com ele - Google Patents

agente de revestimento para stent de liberaÇço de fÁrmaco, mÉtodo para sua preparaÇço e stent de liberaÇço de fÁrmaco revestido com ele

Info

Publication number
BRPI0801740A2
BRPI0801740A2 BRPI0801740-9A BRPI0801740A BRPI0801740A2 BR PI0801740 A2 BRPI0801740 A2 BR PI0801740A2 BR PI0801740 A BRPI0801740 A BR PI0801740A BR PI0801740 A2 BRPI0801740 A2 BR PI0801740A2
Authority
BR
Brazil
Prior art keywords
drug release
release stent
coating agent
preparation
coated therewith
Prior art date
Application number
BRPI0801740-9A
Other languages
English (en)
Inventor
Kyong-Min Shin
Don-Haeng Lee
Kun Na
Eun-Ae Jo
Dong-Ki Lee
Original Assignee
Taewoong Medical Co Ltd
Kyong-Min Shin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from KR1020070053877A external-priority patent/KR100888219B1/ko
Priority claimed from KR1020070103080A external-priority patent/KR100916750B1/ko
Application filed by Taewoong Medical Co Ltd, Kyong-Min Shin filed Critical Taewoong Medical Co Ltd
Publication of BRPI0801740A2 publication Critical patent/BRPI0801740A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

AGENTE DE REVESTIMENTO PARA STENT DE LIBERAÇçO DE FÁRMACO, MÉTODO PARA SUA PREPARAÇçO E STENT DE LIBERAÇçO DE FÁRMACO REVESTIDO COM ELE. A presente invenção refere-se a um agente de revestimento para stents de liberação de fármaco, um método para sua preparação e um stent de liberação de fármaco revestido com ele. O agente de revestimento compreende um material biologicamente ativo e um material de revestimento selecionado dentre acetato de pululano, representado pela Fórmula Química 1 que segue, e uma mistura de tensoativo de poliuretano. [Fórmula Química 1]
BRPI0801740-9A 2007-06-01 2008-06-02 agente de revestimento para stent de liberaÇço de fÁrmaco, mÉtodo para sua preparaÇço e stent de liberaÇço de fÁrmaco revestido com ele BRPI0801740A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020070053877A KR100888219B1 (ko) 2007-06-01 2007-06-01 약물 방출 스텐트용 코팅제, 그의 제조방법 및 이 코팅제로코팅된 약물 방출 스텐트
KR1020070103080A KR100916750B1 (ko) 2007-10-12 2007-10-12 약물 방출 스텐트용 코팅제와 약물 방출 스텐트용 코팅제의제조방법

Publications (1)

Publication Number Publication Date
BRPI0801740A2 true BRPI0801740A2 (pt) 2009-02-10

Family

ID=39790909

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0801740-9A BRPI0801740A2 (pt) 2007-06-01 2008-06-02 agente de revestimento para stent de liberaÇço de fÁrmaco, mÉtodo para sua preparaÇço e stent de liberaÇço de fÁrmaco revestido com ele

Country Status (6)

Country Link
US (1) US8017143B2 (pt)
EP (2) EP2238993A3 (pt)
JP (1) JP5006261B2 (pt)
AU (1) AU2008202283B2 (pt)
BR (1) BRPI0801740A2 (pt)
CA (1) CA2632891A1 (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5860480B2 (ja) 2011-01-11 2016-02-16 キャプシュゲル・ベルジウム・エヌ・ヴィ プルランを含む新しい硬カプセル
KR20120135689A (ko) * 2011-06-07 2012-12-17 (주) 태웅메디칼 약물 방출 스텐트 코팅제의 제조방법 및 이에 의해 제조된 약물 방출 스텐트 코팅제
WO2014169137A1 (en) 2013-04-10 2014-10-16 Massachusetts Institute Of Technology Local drug delivery devices and methods for treating cancer
US10241109B2 (en) 2013-11-08 2019-03-26 Mcmaster University Method of stabilizing molecules without refrigeration using water soluble polymers and applications thereof in performing chemical reactions
KR101765335B1 (ko) * 2014-09-26 2017-08-22 서울대학교산학협력단 암 세포 조영용 ｍｒｉ 조영제 조성물
CA3059529A1 (en) 2017-04-14 2018-10-18 Capsugel Belgium Nv Process for making pullulan
CN110678170A (zh) 2017-04-14 2020-01-10 比利时胶囊公司 普鲁兰多糖胶囊
WO2023091976A1 (en) 2021-11-17 2023-05-25 PanTher Therapeutics, Inc. Implantable and biodegradable drug delivery devices and methods of use thereof
JP2025538459A (ja) 2022-11-17 2025-11-28 パンサー セラピューティクス，インコーポレイティド 膵臓がんを治療する方法
CN119587763B (zh) * 2024-12-16 2025-09-05 上海交通大学 一种用于周围神经缺损修复的具有两面神结构的氢气和镁离子泵导管及其制备方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63313722A (ja) * 1987-06-15 1988-12-21 Towa Yakuhin Kk 経口用抗生物質の徐放化を目的としたプルランアセテ−トマイクロカプセル製剤の製造法
US5092877A (en) 1988-09-01 1992-03-03 Corvita Corporation Radially expandable endoprosthesis
JPH10506560A (ja) 1995-04-19 1998-06-30 シュナイダー（ユーエスエー）インク 薬品を放出する被覆されたステント
KR100439156B1 (ko) 2001-07-05 2004-07-05 주식회사 에스앤지바이오텍 약물 방출 스텐트용 코팅 조성물 및 이의 제조 방법
US6921390B2 (en) * 2001-07-23 2005-07-26 Boston Scientific Scimed, Inc. Long-term indwelling medical devices containing slow-releasing antimicrobial agents and having a surfactant surface
US6702850B1 (en) * 2002-09-30 2004-03-09 Mediplex Corporation Korea Multi-coated drug-eluting stent for antithrombosis and antirestenosis
US7279174B2 (en) * 2003-05-08 2007-10-09 Advanced Cardiovascular Systems, Inc. Stent coatings comprising hydrophilic additives
US7807722B2 (en) * 2003-11-26 2010-10-05 Advanced Cardiovascular Systems, Inc. Biobeneficial coating compositions and methods of making and using thereof
US8309112B2 (en) * 2003-12-24 2012-11-13 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices comprising hydrophilic substances and methods for fabricating the same
US20050220835A1 (en) * 2004-03-30 2005-10-06 Jayaraman Ramesh B Agent eluting bioimplantable devices and polymer systems for their preparation
WO2006031532A2 (en) * 2004-09-10 2006-03-23 Surmodics, Inc. Methods, devices, and coatings for controlled active agent release
EP1830902A2 (en) * 2004-12-30 2007-09-12 Cinvention Ag Combination comprising an agent providing a signal, an implant material and a drug
KR100511618B1 (ko) 2005-01-17 2005-08-31 이경범 약물방출 조절형 다층 코팅 스텐트 및 이의 제조방법
JP2006262960A (ja) * 2005-03-22 2006-10-05 Terumo Corp ステント
WO2007127488A1 (en) * 2006-04-27 2007-11-08 Shenoy Narmada R Compositions and methods for treating or preventing diseases of body passageways

Also Published As

Publication number Publication date
EP2005980A3 (en) 2009-07-08
CA2632891A1 (en) 2008-12-01
EP2238993A3 (en) 2010-10-20
US8017143B2 (en) 2011-09-13
AU2008202283B2 (en) 2011-01-20
EP2238993A2 (en) 2010-10-13
AU2008202283A1 (en) 2008-12-18
JP5006261B2 (ja) 2012-08-22
EP2005980A2 (en) 2008-12-24
JP2008296021A (ja) 2008-12-11
US20080300296A1 (en) 2008-12-04

Similar Documents

Publication Publication Date Title
BRPI0801740A2 (pt) agente de revestimento para stent de liberaÇço de fÁrmaco, mÉtodo para sua preparaÇço e stent de liberaÇço de fÁrmaco revestido com ele
ZA200803350B (en) Method of acting upon organism by targeted delivery of biologically active substances into mitochondria, pharmaceutical composition for carrying out said method, and compound used for the purpose
MY161136A (en) Liquid deodorant composition for textile products
WO2010047765A3 (en) Nanostructures for drug delivery
ATE500854T1 (de) Beschichtete medizinische vorrichtungen und verfahren zu ihrer herstellung
CL2007003000A1 (es) Compuestos derivados de biaril eter urea; composicion farmaceutica que los contienen; y su uso para el tratamiento de enfermedades o afecciones asociadas a la actividad de amida hidrolasa de acidos grasos (faah).
EA201000436A1 (ru) Стероидные [3,2-с]пиразольные соединения, обладающие глюкокортикоидной активностью
EP2055314A4 (en) ACTIVATOR WITH A BIOTENSID AS ACTIVE AGENT, MANNOSYLERYTHRITOL LIPID AND METHOD OF MANUFACTURING THEREOF
CL2009000555A1 (es) Compuestos derivados de tetramatos sustituidos espirociclicamente con 4'4'-dioxaespiro; procedimiento de preparacion; agente para combatir plagas y/o vegetaciones indeseadas que comprende dichos compuestos; su procedimiento de preparacion y uso; composiciones y su uso
BRPI0913587A2 (pt) Composição, agente pesticida, método para controlar fundos prejudiciais fitopatogênicos, semente, uso de um composto e de um outro composto, e, composição.
HN2009000784A (es) Dihidropirazolonas sustituidas
MA33220B1 (fr) Composition pharmaceutique a proprietes anti-inflammatoires
CL2007003244A1 (es) Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
ECSP11010760A (es) Derivados de quinoxalindiona
WO2008112368A3 (en) Phenylalkylcarboxylic acid delivery agents
WO2008110314A8 (de) Fluoralkylphenylamidine und deren verwendung als fungizide
BRPI0815649A8 (pt) Revestimento
CL2008000738A1 (es) Compuestos derivados de malonamida; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de la depresion, enfermedad de parkinson y alzheimer, entre otras enfermeda
AR055319A1 (es) Derivados de isoquinoleina, composiciones farmaceuticas y usos
WO2007031454A3 (en) Coating compositions comprising a latent activator for marking substrates
IL205350A0 (en) Novel 1, 3- dihydro - 5 - isobenzofurancarbonitrile derivatives and pharmacetical composition thereof for the treatment of premature ejaculation
DE602005012950D1 (de) Medizinprodukt mit einem biologischen wirkstoff
WO2008105808A3 (en) FORMULATIONS OF RADIOPROTECTIVE α, β UNSATURATED ARYL SULFONES
BRPI0519070A2 (pt) composiÇço de fator de crescimento de queratinàcito liofilizada, mÉtodos para preparar um fator de crescimento de queratinàcito liofilizado, e para tratar uma doenÇa, e, kit para preparar uma composiÇço farmacÊutica aquosa
PT2155255E (pt) Composições que incluem um composto hidrofóbico e um conjugado de poliaminoácido

Legal Events

Date Code Title Description
B03A Publication of a patent application or of a certificate of addition of invention [chapter 3.1 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2310 DE 14-04-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.